A Swedish nationwide study of 227,000 people with alcohol use disorder found that those taking GLP-1 drugs had 36% lower risk of alcohol-related hospitalizations. This is more than double the 14% reduction that the same study found with naltrexone, which was the best-performing medication approved for treatment of alcohol use disorder in that analysis. Other observational studies have linked GLP-1 drugs to lower rates of new and recurring alcohol use disorder, reduced diagnoses and relapse in cannabis use disorder, fewer health care visits for nicotine dependence and lower risk of opioid overdose.
Also: Everything Apple may unveil at its March event: MacBook M5, iPad 12, and more
，推荐阅读爱思助手下载最新版本获取更多信息
Фото: Yiannis Kourtoglou / Reuters
Credit: ZIMASILK / Amazon
。下载安装汽水音乐对此有专业解读
:first-child]:h-full [&:first-child]:w-full [&:first-child]:mb-0 [&:first-child]:rounded-[inherit] h-full w-full
Иран поразил нефтяной танкер под флагом США у берегов Кувейта14:49。safew官方版本下载对此有专业解读